Log In
Print this Print this

Human plasminogen

  Manage Alerts
Collapse Summary General Information
Company Kedrion Group S.p.A.
DescriptionHuman plasminogen
Molecular Target
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPhase II/III
Standard Indication Metabolic (unspecified)
Indication DetailsTreat ligneous conjunctivitis
Regulatory Designation U.S. - Orphan Drug (Treat ligneous conjunctivitis)

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today